Benjamin A Dahl, Beth Tritter, Deena Butryn, Melissa Dahlke, Sean Browning, Richard Gelting, Monica Fleming, Nancy Ortiz, Jacqueline Labrador, Ryan Novak, David Fitter, Elizabeth Bell, Megan McGuire, Robert Rosenbaum, Robert Pulwer, Jolene Wun, Anna McCaffrey, Maisoon Chowdhury, Nida Parks, Marc Cunningham, Anthony Mounts, Dora Curry, Dominique Richardson, Gavin Grant
{"title":"全球 VAX：2021-2023 年美国对全球 COVID-19 疫苗接种工作的贡献。","authors":"Benjamin A Dahl, Beth Tritter, Deena Butryn, Melissa Dahlke, Sean Browning, Richard Gelting, Monica Fleming, Nancy Ortiz, Jacqueline Labrador, Ryan Novak, David Fitter, Elizabeth Bell, Megan McGuire, Robert Rosenbaum, Robert Pulwer, Jolene Wun, Anna McCaffrey, Maisoon Chowdhury, Nida Parks, Marc Cunningham, Anthony Mounts, Dora Curry, Dominique Richardson, Gavin Grant","doi":"10.1016/j.vaccine.2024.03.054","DOIUrl":null,"url":null,"abstract":"<p><p>In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and multilateral organizations, Global VAX enabled the rapid acceleration of the global COVID-19 vaccine rollout in selected countries, contributing to increased COVID-19 vaccine coverage in some of the world's most vulnerable communities. Through Global VAX, the U.S. Government has supported 125 countries to scale up COVID-19 vaccine delivery and administration while strengthening primary health care systems to respond to future health crises. The progress made by Global VAX has paved the way for a stronger global recovery and improved global health security.</p>","PeriodicalId":94264,"journal":{"name":"Vaccine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417132/pdf/","citationCount":"0","resultStr":"{\"title\":\"Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023.\",\"authors\":\"Benjamin A Dahl, Beth Tritter, Deena Butryn, Melissa Dahlke, Sean Browning, Richard Gelting, Monica Fleming, Nancy Ortiz, Jacqueline Labrador, Ryan Novak, David Fitter, Elizabeth Bell, Megan McGuire, Robert Rosenbaum, Robert Pulwer, Jolene Wun, Anna McCaffrey, Maisoon Chowdhury, Nida Parks, Marc Cunningham, Anthony Mounts, Dora Curry, Dominique Richardson, Gavin Grant\",\"doi\":\"10.1016/j.vaccine.2024.03.054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and multilateral organizations, Global VAX enabled the rapid acceleration of the global COVID-19 vaccine rollout in selected countries, contributing to increased COVID-19 vaccine coverage in some of the world's most vulnerable communities. Through Global VAX, the U.S. Government has supported 125 countries to scale up COVID-19 vaccine delivery and administration while strengthening primary health care systems to respond to future health crises. The progress made by Global VAX has paved the way for a stronger global recovery and improved global health security.</p>\",\"PeriodicalId\":94264,\"journal\":{\"name\":\"Vaccine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11417132/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vaccine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.vaccine.2024.03.054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.vaccine.2024.03.054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Global VAX: A U.S. contribution to global COVID-19 vaccination efforts, 2021-2023.
In December 2021 the U.S. Government announced a new, whole-of-government $1.8 billion effort, the Initiative for Global Vaccine Access (Global VAX) in response to the global COVID-19 pandemic. Using the foundation of decades of U.S. government investments in global health and working in close partnership with local governments and key global and multilateral organizations, Global VAX enabled the rapid acceleration of the global COVID-19 vaccine rollout in selected countries, contributing to increased COVID-19 vaccine coverage in some of the world's most vulnerable communities. Through Global VAX, the U.S. Government has supported 125 countries to scale up COVID-19 vaccine delivery and administration while strengthening primary health care systems to respond to future health crises. The progress made by Global VAX has paved the way for a stronger global recovery and improved global health security.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
